Hyperbaric oxygen therapy for perineal Crohn's disease

Charles M. Noyer, Lawrence J. Brandt

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Perineal lesions are a frequent and troublesome complication of Crohn's disease. Although there are various surgical and medical therapeutic regimens available to treat these lesions, all have significant associated morbidity, mortality, and toxicity. Recently, the beneficial effects of hyperbaric oxygen therapy (HBOT) have been described in patients with severe or refractory perineal disease, but the role of HBOT in larger groups or less severely affected patients has not yet been studied, nor has the minimum number of treatments required for initial or complete healing of perineal disease in this population been described. This article reviews the known and theoretical tissue effects of HBOT and discusses its potential role in treating patients with perineal Crohn's disease.

Original languageEnglish (US)
Pages (from-to)318-321
Number of pages4
JournalAmerican Journal of Gastroenterology
Volume94
Issue number2
DOIs
StatePublished - Feb 1999

Fingerprint

Hyperbaric Oxygenation
Crohn Disease
Morbidity
Mortality
Therapeutics
Population

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hyperbaric oxygen therapy for perineal Crohn's disease. / Noyer, Charles M.; Brandt, Lawrence J.

In: American Journal of Gastroenterology, Vol. 94, No. 2, 02.1999, p. 318-321.

Research output: Contribution to journalArticle

@article{a0fdc9ff69fc4c259ab7a48618fdaff8,
title = "Hyperbaric oxygen therapy for perineal Crohn's disease",
abstract = "Perineal lesions are a frequent and troublesome complication of Crohn's disease. Although there are various surgical and medical therapeutic regimens available to treat these lesions, all have significant associated morbidity, mortality, and toxicity. Recently, the beneficial effects of hyperbaric oxygen therapy (HBOT) have been described in patients with severe or refractory perineal disease, but the role of HBOT in larger groups or less severely affected patients has not yet been studied, nor has the minimum number of treatments required for initial or complete healing of perineal disease in this population been described. This article reviews the known and theoretical tissue effects of HBOT and discusses its potential role in treating patients with perineal Crohn's disease.",
author = "Noyer, {Charles M.} and Brandt, {Lawrence J.}",
year = "1999",
month = "2",
doi = "10.1111/j.1572-0241.1999.00848.x",
language = "English (US)",
volume = "94",
pages = "318--321",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Hyperbaric oxygen therapy for perineal Crohn's disease

AU - Noyer, Charles M.

AU - Brandt, Lawrence J.

PY - 1999/2

Y1 - 1999/2

N2 - Perineal lesions are a frequent and troublesome complication of Crohn's disease. Although there are various surgical and medical therapeutic regimens available to treat these lesions, all have significant associated morbidity, mortality, and toxicity. Recently, the beneficial effects of hyperbaric oxygen therapy (HBOT) have been described in patients with severe or refractory perineal disease, but the role of HBOT in larger groups or less severely affected patients has not yet been studied, nor has the minimum number of treatments required for initial or complete healing of perineal disease in this population been described. This article reviews the known and theoretical tissue effects of HBOT and discusses its potential role in treating patients with perineal Crohn's disease.

AB - Perineal lesions are a frequent and troublesome complication of Crohn's disease. Although there are various surgical and medical therapeutic regimens available to treat these lesions, all have significant associated morbidity, mortality, and toxicity. Recently, the beneficial effects of hyperbaric oxygen therapy (HBOT) have been described in patients with severe or refractory perineal disease, but the role of HBOT in larger groups or less severely affected patients has not yet been studied, nor has the minimum number of treatments required for initial or complete healing of perineal disease in this population been described. This article reviews the known and theoretical tissue effects of HBOT and discusses its potential role in treating patients with perineal Crohn's disease.

UR - http://www.scopus.com/inward/record.url?scp=0033083772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033083772&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.1999.00848.x

DO - 10.1111/j.1572-0241.1999.00848.x

M3 - Article

VL - 94

SP - 318

EP - 321

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 2

ER -